Publicaciones en colaboración con investigadores/as de Heidelberg University (12)

2020

  1. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

    Nature Genetics, Vol. 52, Núm. 1, pp. 56-73

2018

  1. Epigenetically regulated chromosome 14q32 miRNA cluster induces metastasis and predicts poor prognosis in lung adenocarcinoma patients

    Molecular Cancer Research, Vol. 16, Núm. 3, pp. 390-402

2016

  1. MicroRNAs are key regulators of hepatocellular carcinoma (HCC) cell dissemination - what we learned from microRNA-494

    HEPATOBILIARY SURGERY AND NUTRITION

  2. Patch-Based Nonlinear Image Registration for Gigapixel Whole Slide Images

    IEEE Transactions on Biomedical Engineering, Vol. 63, Núm. 9, pp. 1812-1819

2015

  1. Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cells

    Journal of Pathology, Vol. 237, Núm. 3, pp. 390-401

2014

  1. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers

    Breast Cancer Research, Vol. 16

2013

  1. Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

    PLoS Genetics, Vol. 9, Núm. 3

2012

  1. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers

    Cancer Epidemiology Biomarkers and Prevention, Vol. 21, Núm. 4, pp. 645-657

  2. The Eutherian Armcx genes regulate mitochondrial trafficking in neurons and interact with Miro and Trak2

    Nature Communications, Vol. 3

2011

  1. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers

    Journal of the National Cancer Institute, Vol. 103, Núm. 2, pp. 105-116

2010

  1. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction

    Cancer Research, Vol. 70, Núm. 23, pp. 9742-9754

2009

  1. The TP53 Arg72Pro and MDM2 309GT polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers

    British Journal of Cancer, Vol. 101, Núm. 8, pp. 1456-1460